Literature DB >> 27510817

Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.

Pei-Hao Wen1,2, Dong-Yu Wang3, Jia-Kai Zhang1,2, Zhi-Hui Wang1,2, Jie Pan1,2, Xiao-Yi Shi1,2, Han Yang1,2, Shui-Jun Zhang1,2, Wen-Zhi Guo4,2.   

Abstract

Kruppel-like factor 6 (KLF6) as a novel tumor suppressive gene participates in multiple biological behaviors and plays an important role in regulating tumor cell growth and invasion. However, the functions of KLF6 in hepatocellular carcinoma (HCC) remain poorly understood. The expression level of KLF6 was examined by immunohistochemical assay in human HCC tissues, and KLF6-overexpressed HCC cells (SMCC-7721 and HepG2) were used for evaluating cell proliferation and invasion by MTT and Transwell assays. A subcutaneous HCC tumor model was established for assessing tumor growth in vivo. Our results showed that the expression of KLF6 was significantly downregulated in HCC tissues compared with the adjacent non-cancerous tissues (50.0% vs. 72.0%, P = 0.034) and negatively associated with the lymph-vascular space invasion (LVSI) in HCC patients (P = 0.003). Furthermore, overexpression of KLF6 reduced cell proliferation and weakened the cell invasive potential followed with the decreased expression of PCNA and MMP-9 in HCC cells. The in vivo experiment indicated that KLF6 overexpression suppressed the xenograft tumor growth. Therefore, our findings show that KLF6 suppresses growth and invasion of HCC cells in vitro and in vivo, suggesting a tumor suppressive function in HCC and provides the potential therapeutic target for the treatment of HCC.
© The Author(s) 2016.

Entities:  

Keywords:  Kruppel-like factor 6; growth; hepatocellular carcinoma; invasion

Mesh:

Substances:

Year:  2016        PMID: 27510817      PMCID: PMC5806821          DOI: 10.1177/0394632016655171

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  22 in total

1.  New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma.

Authors:  Zhou Zhenzhen; Tian De'an; Xia Limin; Yan Wei; Luo Min
Journal:  Hepatogastroenterology       Date:  2012 Mar-Apr

Review 2.  Emerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.

Authors:  Analisa DiFeo; Goutham Narla; John A Martignetti
Journal:  Mt Sinai J Med       Date:  2009-12

3.  Increased expression of the oncogenic KLF6-SV1 transcript in human glioblastoma.

Authors:  Andrei Tchirkov; Vincent Sapin; Geoffroy Marceau; Emmanuel Chautard; Goutham Narla; Lauren Veronese; Scott Friedman; Toufic Khalil; Philippe Vago; Jean-Louis Kemeny; Pierre Verrelle
Journal:  Clin Chem Lab Med       Date:  2010-08       Impact factor: 3.694

4.  Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.

Authors:  Wei-Cheng Liang; Yan Wang; Li-Jia Xiao; Yu-Bing Wang; Wei-Ming Fu; Wei-Mao Wang; Hui-Qing Jiang; Wei Qi; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  RNA Biol       Date:  2014-06-12       Impact factor: 4.652

5.  Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene.

Authors:  Ursula E Lee; Zahra Ghiassi-Nejad; Andrew J Paris; Steven Yea; Goutham Narla; Martin Walsh; Scott L Friedman
Journal:  FEBS Lett       Date:  2010-01-30       Impact factor: 4.124

6.  Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.

Authors:  Ricardo C Gehrau; Diego S D'Astolfo; Verónica Andreoli; José L Bocco; Nicolás P Koritschoner
Journal:  Mutat Res       Date:  2010-12-13       Impact factor: 2.433

Review 7.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Functional role of the KLF6 tumour suppressor gene in gastric cancer.

Authors:  Jaya Sangodkar; Jiayan Shi; Analisa DiFeo; Rachel Schwartz; Romina Bromberg; Aisha Choudhri; Kim McClinch; Raheleh Hatami; Elias Scheer; Sigal Kremer-Tal; John A Martignetti; Alex Hui; W K Leung; Scott L Friedman; Goutham Narla
Journal:  Eur J Cancer       Date:  2008-12-26       Impact factor: 9.162

Review 9.  The role of interventional radiology in the management of hepatocellular carcinoma.

Authors:  N Molla; N AlMenieir; E Simoneau; M Aljiffry; D Valenti; P Metrakos; L M Boucher; M Hassanain
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

10.  Expression and significance of Kruppel-like factor 6 gene in osteosarcoma.

Authors:  Kai Chen; Yu Chen; Xiao-dong Zhu; Yu-shu Bai; Xian-zhao Wei; Chuan-feng Wang; Zi-qiang Chen; Ming Li
Journal:  Int Orthop       Date:  2012-08-02       Impact factor: 3.075

View more
  6 in total

1.  Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma.

Authors:  Wen-Juan Huang; Guang-Yu Wang; Zeng-Yao Liu; Meng-Lin Zhang; Wen Wang; Xin Zhang; Rui-Tao Wang
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

2.  KLF6 inhibited oral cancer migration and invasion via downregulation of mesenchymal markers and inhibition of MMP-9 activities.

Authors:  Li-Sung Hsu; Ren-Hung Huang; Hung-Wen Lai; Hui-Ting Hsu; Wen-Wei Sung; Ming-Ju Hsieh; Chong-Yu Wu; Yueh-Min Lin; Mu-Kuan Chen; Yu-Sheng Lo; Chih-Jung Chen
Journal:  Int J Med Sci       Date:  2017-04-09       Impact factor: 3.738

3.  Overexpression of the Oncogenic Variant (KLF6-SV1) in Young NPC Patients and Correlation with Lack of E-Cadherin.

Authors:  Saoussen Debouki-Joudi; Sonia Mhirsi; Nehla Mokni-Baizig; Nihel Ammous-Boukhris; Hayet Mhamdi; Said Gritli; Raja Mokdad Gargouri; Mohamed Nejib Marzouki
Journal:  Anal Cell Pathol (Amst)       Date:  2018-04-19       Impact factor: 2.916

4.  KLF6-SV1 is a new prognostic biomarker in postoperative patients with non-small cell lung cancer.

Authors:  Nan Zhang; Zhe Li; Wei Xiao; Fei Yang; Wei Gao; Zhi-Gang Sun
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

5.  SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2.

Authors:  Fei-Fei Pu; De-Yao Shi; Ting Chen; Yu-Xuan Liu; Bin-Long Zhong; Zhi-Cai Zhang; Wei-Jian Liu; Qiang Wu; Bai-Chuan Wang; Zeng-Wu Shao; Tong-Chuan He; Jian-Xiang Liu
Journal:  Cell Death Dis       Date:  2021-01-11       Impact factor: 8.469

6.  Krüppel-Like Factor 6 Downregulation Is Connected with a Poor Prognosis and Tumor Growth in Non-Small-Cell Lung Cancer.

Authors:  Binbin Zeng; Jiaxin Lin; Xingdong Cai; Li Che; Wei Zeng; Shengming Liu
Journal:  Comput Math Methods Med       Date:  2022-01-30       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.